Stocks · Health care · Surgical & Medical Instruments & Apparatus

AtriCure, Inc.

ATRC Clue Score58
United States Fiscal year ends December CIK 0001323885 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Regina E Groves
11 Sep 2026
Director
Sell
5,313
$54.22
$288.07K
Karl S. Dahlquist
24 Aug 2026
Chief Legal Officer
Sell
9,370
$48.89
$458.10K
Maggie Yuen
5 Aug 2026
Director
Sell
3,500
$38.42
$134.47K
Karen Prange
5 Aug 2026
Director
Sell
3,564
$38.80
$138.28K
Justin J Noznesky
29 Jul 2026
Chief Mktg & Strategy Officer
Sell
6,182
$38.80
$239.86K
Vinayak Doraiswamy
28 Jul 2026
Chief Scientific Officer
Sell
6,000
$38.88
$233.28K
Karen Prange
20 May 2026
Director
Sell
3,000
$28.65
$85.95K
Vinayak Doraiswamy
15 May 2026
Chief Scientific Officer
Sell
5,000
$28.13
$140.65K
Vinayak Doraiswamy
12 Mar 2026
Chief Scientific Officer
Sell
5,000
$29.83
$149.15K
Justin J Noznesky
26 Nov 2025
Chief Mktg & Strategy Officer
Sell
5,166
$37.29
$192.64K
Maggie Yuen
21 Nov 2025
Director
Sell
3,000
$35.72
$107.16K

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 3
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 775,313
History held since 7 Feb 2007